A functional androgen receptor is not sufficient to allow estradiol to protect bone after gonadectomy in estradiol receptor-deficient mice

Journal of Clinical Investigation

Volumn 111, Issue 9, 2003, Pages 1319-1327

  Sims, Natalie A ^a,b   Clément Lacroix, Philippe ^c   Minet, Dominique ^c   Fraslon Vanhulle, Caroline ^d   Galliard Kelly, Martine ^d   Resche Rigon, Michèle ^c   Baron, Roland ^a,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Proskelia Pharmaceuticals   (France)

^d SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ESTRADIOL; ESTRADIOL RECEPTOR; ESTRADIOL RECEPTOR ALPHA; ESTRADIOL RECEPTOR BETA; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANDROGEN METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METABOLISM; BONE TISSUE; CONTROLLED STUDY; FEMALE; GENDER; GONADECTOMY; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; KNOCKOUT GENE; MALE; MOUSE; NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN FUNCTION; RECEPTOR BINDING; REGULATORY MECHANISM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANDROGEN ANTAGONISTS; ANIMALS; BONE AND BONES; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; MALE; MICE; MICE, KNOCKOUT; ORCHIECTOMY; OVARIECTOMY; PROTEIN ISOFORMS; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; TESTOSTERONE;

EID: 0038326757     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200317246     Document Type: Article

References (28)

1. Turner, R.T., Riggs, B.L., and Spelsberg, T.C. 1994. Skeletal effects of estrogen. Endocr. Rev. 15:275-300.
2. Lindsay, R., et al. 1976. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancer. 1:1038-1041.
3. Oz, O.K., et al. 2000. Bone has a sexually dimorphic response to aromatase deficiency. J. Bone Miner Res. 15:507-514.
4. Miyaura, C., et al. 2001. Sex- and age-related response to aromatase deficiency in bone. Biochem. Biophys. Res. Commun. 280:1062-1068.
5. Rochira, V., Balestrieri, A., Faustini-Fustini, M., and Carani, C. 2001. Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency. Mol. Cell. Endocrinol. 178:215-220.
6. Komm, B.S., et al. 1988. Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science. 241:81-84.
7. Onoe, Y., Miyaura, C., Ohta, H., Nozawa, S., and Suda, T. 1997. Expression of estrogen receptor beta in rat bone. Endocrinology. 138:4509-4512.
8. Vidal, O., Kindblom, L.G., and Ohlsson, C. 1999. Expression and localization of estrogen receptor-beta in murine and human bone. J. Bone Miner. Res. 14:923-929.
9. Kousteni, S., et al. 2001. Nongenorropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell. 104:719-730.
10. Kousteni, S., et al. 2002. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 298:843-846.
11. Windahl, S.H., et al. 2001. Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss. J. Bone Miner. Res. 16:1388-1398.
12. Vidal, O., et al. 2000. Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc. Natl. Acad. Sci. U. S. A. 97:5474-5479.
13. Sims, N.A., et al. 2002. Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. Bone. 30:18-25.
14. Couse, J.F., et al. 1995. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 9:1441-1454.
15. Denger, S., et al. 2001. ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol. Endocrinol. 15:2064-2077.
16. Krege, J.H., et al. 1998. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc. Natl. Acad. Sci. U. S. A. 95:15677-15682.
17. Pendaries, C., et al. 2002. The AF-1 activation-function of ERalpha may be dispensable to mediate the effect of estradiol on endothelial NO production in mice. Proc. Natl. Acad. Sci. U. S. A. 99:2205-2210.
18. Dupont, S., et al. 2000. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development. 127:4277-4291.
19. Van de Velde, P., et al. 1996. RU 58,668: further in vitro and in vivo pharmacotogical data related to its antitumoral activity. J. Steroid Biochem. Mol. Biol. 59:449-457.
20. Battmann, T., et al. 1998. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders. J. Steroid Biochem. Mol. Biol. 64:103-111.
21. Teutsch, G., et al. 1994. Non-steroidal antiandrogens: synthesis and biological profile of high-affinity ligands for the androgen receptor. J. Steroid Biochem. Mol. Biol. 48:111-119.
22. Sims, N.A., et al. 2000. Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J. Clin. Invest. 106:1095-1103.
23. Hofbauer, L.C., Hicok, K.C., and Khosla, S. 1998. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line. J. Cell Biochem. 71:96-108.
24. Katznelson, L., et al. 1996. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J. Clin. Endocrinol. Metab. 81:4358-4365.
25. Anderson, F.H., Francis, R.M., Peaston, R.T., and Wastell, H.J. 1997. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption. J. Bone Miner. Res. 12:472-478.
26. Vandenput, L., et al. 2001. Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. Biochem. Biophys. Res. Commun. 285:70-76.
27. Gentile, M.A., Zhang, H., Harada, S., Rodan, G.A., and Kimmel, D.B. 2001. Bone response to estrogen replacement in OVX double estrogen receptor-(α and β) knockout mice. J. Bone Miner. Res. 16(Suppl. 1):S146. (Abstr.)
28. Hall, J.M., and McDonnell, D.P. 1999. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology. 140:5566-5578.